46_CD Group_NNP profit_NN and_CC loss_NN account_NN FOR_IN THE_DT YEAR_NN ENDED_VBD 31_CD DECEMBER_NNP 2003 2003 2002 2001_CD Notes_NNP m_FW m_FW m_FW A_DT Turnover_NN 2_CD 169.1_CD 79.7_CD 8.9_CD Cost_NN of_IN sales_NNS 98.4_CD 49.2_CD 5.1_CD Gross_NNP profit_NN 70.7_CD 30.5_CD 3.8_CD Research_NNP and_CC development_NN costs_NNS 19.9_CD 16.5_CD 13.0_CD Sales_NNS and_CC marketing_NN costs_NNS 1.3_CD Administrative_JJ costs_NNS including_VBG amortisation_NN of_IN goodwill_NN 3_CD 4.7_CD 4.3_CD 3.5_CD Exceptional_JJ administrative_JJ item_NN :_: settlement_NN of_IN BTG_NNP agreement_NN 3,4_CD 7.4_CD Group_NNP operating_NN profit_NN loss_NN 37.4_CD 9.7_CD 12.7_CD Interest_NN receivable_NN and_CC similar_JJ income_NN 2.1_CD 0.7_CD 0.9_CD Amounts_NNS released_VBN provided_VBN against_IN fixed_VBN asset_NN investment_NN 5_CD 0.5_CD 0.1_CD 0.4_CD Interest_NN payable_JJ and_CC similar_JJ charges_NNS 6_CD 1.0_CD 1.2_CD 0.2_CD Exchange_NNP gain_NN loss_NN on_IN foreign_JJ currency_NN borrowings_NNS 19_CD 0.4_CD 0.5_CD 0.1_CD A_DT Profit_NN loss_NN on_IN ordinary_JJ activities_NNS before_IN taxation_NN 7_CD 39.4_CD 9.6_CD 12.5_CD B_NNP Taxation_NNP 10_CD 3.9_CD 0.1_CD Profit_NN loss_NN on_IN ordinary_JJ activities_NNS after_IN taxation_NN being_VBG retained_VBN profit_NN loss_NN for_IN the_DT financial_JJ year_NN 35.5_CD 9.6_CD 12.4_CD Earnings_NNS loss_NN per_IN ordinary_JJ share_NN basic_JJ 11_CD 34.5_CD p_NN 10.0_CD p_VBP 13.7_CD p_JJ Earnings_NNS loss_NN per_IN ordinary_JJ share_NN fully_RB diluted_VBN 11_CD 34.0_CD p_NN 9.7_CD p_VBP 13.7_CD p_JJ A_DT statement_NN of_IN movements_NNS on_IN reserves_NNS is_VBZ given_VBN in_IN note_NN 24_CD ._.
The_DT accompanying_JJ notes_NNS are_VBP an_DT integral_JJ part_NN of_IN this_DT Group_NNP profit_NN and_CC loss_NN account_NN ._.
All_DT amounts_NNS in_IN 2003_CD arise_VB from_IN continuing_VBG operations_NNS ._.
The_DT results_NNS of_IN the_DT Groups_NNS acquisition_NN during_IN 2003_CD are_VBP not_RB material_JJ to_TO the_DT Group_NNP see_VB note_NN 15_CD ._.
Group_NNP statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS FOR_IN THE_DT YEAR_NN ENDED_VBD 31_CD DECEMBER_NNP 2003 2003 2002 2001_CD m_FW m_FW m_FW Profit_NN loss_NN for_IN the_DT year_NN 35.5_CD 9.6_CD 12.4_CD Loss_NN gain_NN on_IN foreign_JJ currency_NN translation_NN 3.8_CD 1.3_CD 0.3_CD Total_JJ recognized_VBN gains_NNS and_CC losses_NNS for_IN the_DT financial_JJ year_NN 31.7_CD 10.9_CD 12.7_CD The_DT accompanying_JJ notes_NNS are_VBP an_DT integral_JJ part_NN of_IN this_DT Group_NNP statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS ._.
THE_DT INFORMATION_NNP IN_IN THIS_NNP BORDER_NNP HAS_VBZ NOT_RB BEEN_JJ AUDITED_JJ A_DT TURNOVER_NN AND_CC PROFIT_NN LOSS_NN ON_IN ORDINARY_NNP B_NNP TAXATION_NNP C_NNP STOCK_NNP AND_CC DEBTORS_NNS :_: AMOUNTS_NNS RECEIVABLE_NN WITHIN_IN ONE_CD YEAR_NN ACTIVITIES_NNS BEFORE_VBP TAXATION_NN IN_IN 2003_CD WE_NNP RECORDED_NNP A_NNP 3.9_CD M_NNP TAX_NN CHARGE_NN COMPARED_VBN BOTH_DT STOCK_NN AND_CC DEBTORS_NNS REDUCED_VBN DURING_IN 2003_CD ._.
AT_NNP THE_DT IN_IN 2003_CD ,_, ACAMBIS_NNP REPORTED_VBD RECORD_NN FINANCIAL_NNP RESULTS_NNP TO_TO ZERO_NNP IN_IN 2002_CD ._.
ACAMBIS_NNP RECORDED_NNP ITS_NNP MAIDEN_NNP PROFITS_NNS END_VBP OF_IN 2002_CD THE_DT STOCK_NN BALANCE_NN RELATED_VBN TO_TO SMALLPOX_NNP WITH_IN ALMOST_NNP A_NNP FOUR-FOLD_NNP INCREASE_NNP IN_IN PROFITS_NNS BEFORE_IN IN_IN 2002_CD ,_, SINCE_NNP WHICH_WDT TIME_NNP THE_DT MAJORITY_NN OF_IN THE_DT GROUPS_NNS VACCINE_VBP THAT_WDT WAS_VBD SHIPPED_VBN TO_TO THE_DT CDC_NNP DURING_NNP 2003_CD ._.
REVENUE_NN IN_IN THE_DT YEAR_NN INCREASED_VBN HISTORIC_NNP TAX_NN LOSSES_VBZ HAVE_NNP BEEN_NNP UTILISED_NNP ._.
THE_DT EFFECTIVE_NNP DEBTORS_NNPS AT_NNP THE_DT END_NNP OF_IN 2002_CD INCLUDED_VBD AMOUNTS_NNS OWED_VBN FROM_IN 79.7_CD M_NNP IN_IN 2002_CD TO_TO 169.1_CD M_NNP IN_IN 2003_CD PRINCIPALLY_NNP AS_NNP TAX_NN RATE_NN IN_IN 2003_CD WAS_VBD 10_CD %_NN ,_, AND_CC WE_VBP EXPECT_VB THIS_NNS WILL_MD BY_IN THE_DT CDC_NNP UNDER_IN THE_DT SMALLPOX_NNP VACCINE_NNP CONTRACT_NNP A_NNP RESULT_NNP OF_IN INCREASED_NNP ACTIVITY_NNP UNDER_IN OUR_NNP SMALLPOX_NNP INCREASE_NNP TO_TO BETWEEN_NNP 30_CD %_NN AND_CC 35_CD %_NN IN_IN 2004_CD ._.
VACCINE_NN PROGRAMME_NNP WITH_IN THE_DT CDC_NNP ._.
